O006 : C-swift: grazoprevir/elbasvir + sofosbuvir in cirrhotic and noncirrhotic, treatment-naive patients with hepatitis C virus genotype 1 infection, for durations of 4, 6 or 8 weeks and genotype 3 infection for durations of 8 or 12 weeks

Journal of Hepatology ◽

10.1016/s0168-8278(15)30013-1 ◽

2015 ◽

Vol 62 ◽

pp. S192-S193 ◽

Cited By ~ 31

Author(s):

F. Poordad ◽

E. Lawitz ◽

J.A. Gutierrez ◽

B. Evans ◽

A. Howe ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Genotype 1 ◽

Genotype 3 ◽

Virus Genotype ◽

Treatment Naïve

Download Full-text

Faculty Opinions recommendation of Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718196356.793490906 ◽

2014 ◽

Author(s):

Arthur Kim

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Randomized Trial ◽

Low Dose ◽

Pegylated Interferon ◽

Genotype 1 ◽

Virus Genotype ◽

Interferon Α2a ◽

Treatment Naïve

Download Full-text

Vaniprevir plus peginterferon alfa-2b and ribavirin in treatment-naive Japanese patients with hepatitis C virus genotype 1 infection: a randomized phase III study

Journal of Gastroenterology ◽

10.1007/s00535-015-1120-x ◽

2015 ◽

Vol 51 (4) ◽

pp. 390-403 ◽

Cited By ~ 15

Author(s):

Norio Hayashi ◽

Makoto Nakamuta ◽

Tetsuo Takehara ◽

Hiromitsu Kumada ◽

Akiko Takase ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Japanese Patients ◽

Phase Iii ◽

Genotype 1 ◽

Virus Genotype ◽

Treatment Naïve ◽

Phase Iii Study ◽

Peginterferon Alfa

Download Full-text

P1233 EFFICACY AND SAFETY OF MK-5172 PLUS RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 1 INFECTION: FINAL RESULTS OF THE C-SPIRIT STUDY

Journal of Hepatology ◽

10.1016/s0168-8278(14)61393-3 ◽

2014 ◽

Vol 60 (1) ◽

pp. S499 ◽

Cited By ~ 1

Author(s):

E. Gane ◽

Z. Ben Ari ◽

L. Mollison ◽

E. Zuckerman ◽

R. Bruck ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Efficacy And Safety ◽

Genotype 1 ◽

Virus Genotype ◽

Treatment Naïve

Download Full-text

Financial Impact of Two Different Ways of Evaluating Early Virological Response to Peginterferon-??-2b Plus Ribavirin Therapy in Treatment-Naive Patients with Chronic Hepatitis C Virus Genotype 1

PharmacoEconomics ◽

10.2165/00019053-200523100-00007 ◽

2005 ◽

Vol 23 (10) ◽

pp. 1043-1055 ◽

Cited By ~ 15

Author(s):

Maria Buti ◽

Miguel A Casado ◽

Leslie Fosbrook ◽

Rafael Esteban

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Virological Response ◽

Financial Impact ◽

Early Virological Response ◽

Genotype 1 ◽

Virus Genotype ◽

Chronic Hepatitis C Virus ◽

Treatment Naïve

Download Full-text

Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection

Annals of Internal Medicine ◽

10.7326/m15-0785 ◽

2015 ◽

Vol 163 (1) ◽

pp. 1 ◽

Cited By ~ 374

Author(s):

Stefan Zeuzem ◽

Reem Ghalib ◽

K. Rajender Reddy ◽

Paul J. Pockros ◽

Ziv Ben Ari ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Genotype 1 ◽

Virus Genotype ◽

Chronic Hepatitis C Virus ◽

Treatment Naïve

Download Full-text

Therapeutic Approach to the Treatment-Naive Patient With Hepatitis C Virus Genotype 1 Infection: A Step-by-Step Approach

Clinical Infectious Diseases ◽

10.1093/cid/cis628 ◽

2012 ◽

Vol 55 (9) ◽

pp. 1236-1241 ◽

Cited By ~ 3

Author(s):

K. E. Sherman

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Therapeutic Approach ◽

Genotype 1 ◽

Virus Genotype ◽

Naive Patient ◽

Treatment Naïve

Download Full-text

Pharmacokinetic Interactions between Simeprevir and Ledipasvir in Treatment-Naïve Hepatitis C Virus Genotype 1-Infected Patients without Cirrhosis Treated with a Simeprevir/Sofosbuvir/Ledipasvir Regimen

Journal of Hepatology ◽

10.1016/s0168-8278(16)01604-4 ◽

2016 ◽

Vol 64 (2) ◽

pp. S820

Author(s):

S. Bourgeois ◽

Y. Horsmans ◽

F. Nevens ◽

H. van Vlierberghe ◽

C. Moreno ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Genotype 1 ◽

Virus Genotype ◽

Pharmacokinetic Interactions ◽

Treatment Naïve

Download Full-text

LP02 : C-surfer: grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and chronic kidney disease

Journal of Hepatology ◽

10.1016/s0168-8278(15)30156-2 ◽

2015 ◽

Vol 62 ◽

pp. S263-S264 ◽

Cited By ~ 25

Author(s):

D. Roth ◽

D. Nelson ◽

A. Bruchfeld ◽

A. Liapakis ◽

M. Silva ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Kidney Disease ◽

Genotype 1 ◽

Virus Genotype ◽

Treatment Naïve

Download Full-text

FP267C-SURFER: GRAZOPREVIR PLUS ELBASVIR IN TREATMENT-NAIVE AND TREATMENT-EXPERIENCED PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 1 INFECTION AND CHRONIC KIDNEY DISEASE

Nephrology Dialysis Transplantation ◽

10.1093/ndt/gfv174.02 ◽

2015 ◽

Vol 30 (suppl_3) ◽

pp. iii156-iii156 ◽

Cited By ~ 1

Author(s):

Annette Bruchfeld ◽

David Roth ◽

David Nelson ◽

AnneMarie Liapakis ◽

Marcelo Silva ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Kidney Disease ◽

Genotype 1 ◽

Virus Genotype ◽

Treatment Naïve

Download Full-text

Faculty Opinions recommendation of Randomized controlled trial of danoprevir plus peginterferon alfa-2a and ribavirin in treatment-naïve patients with hepatitis C virus genotype 1 infection.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718025097.793482339 ◽

2013 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Randomized Controlled Trial ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Controlled Trial ◽

Genotype 1 ◽

Virus Genotype ◽

Randomized Controlled ◽

Treatment Naïve ◽

Peginterferon Alfa

Download Full-text